Watch-and-wait management is viable for rectal cancers not palpable on exam, keeping patient outcomes comparable. 3-year local regrowth-free survival rates: 81.4% for palpable vs. 74.3% for nonpalpable tumors. 3-year disease-free survival rates: 80.8% for palpable vs. 74.3% for nonpalpable tumors. Surgeons can confidently consider watch-and-wait for these cases without compromising efficacy. Initial clinical responses don’t […]
Category: General Surgery
New Guidelines for Splanchnic Venous Thrombosis Post-Splenectomy
Splanchnic venous thrombosis is a critical yet often overlooked risk after splenectomy in hematologic patients. Incidence is 11.4%, rising to 20.7% with routine imaging and 15.1% in single-center studies. Major risk factors include splenic size and weight; age, BMI, and platelet count were not significant. Patients with myeloproliferative neoplasms, lymphoma, and thalassemia face the highest […]
Uncut Roux-en-Y Outperforms Billroth in Gastrectomy Recovery
Uncut Roux-en-Y significantly reduces bile reflux and enhances quality of life post-distal gastrectomy for gastric cancer. Bile reflux incidence at 3 months: uncut R-Y (6.8%) vs. Billroth-II (77.6%) and Billroth II Braun (63.6%), p < 0.001. Results held at 12 months: 10.5% for uncut R-Y compared to 86% for Billroth-II and 67.9% for Billroth II […]
Enhancing Laparoscopic Cholecystectomy Safety with Ultrasound
Intraoperative ultrasound significantly improves safety during complex laparoscopic cholecystectomy. Intraoperative ultrasound reduced intraoperative iatrogenic rupture from 17.11% to 3.95% (p = 0.017). It improved differentiation between cystic duct stones and adhered structures. Integrating ultrasound with the modified gallbladder reporting and data system enhances decision-making, especially in higher-risk cases. The rate of atypical hyperplasia increased significantly […]
Long-Term Success of Laparoscopic Nissen Fundoplication
Laparoscopic Nissen fundoplication shows strong long-term effectiveness for GERD with high patient satisfaction over 10 years. Heartburn prevalence dropped from 94% to 34% post-surgery. Overall patient satisfaction reached 87%, with 87% willing to repeat the procedure. Consider LNF for candidates seeking durable symptom relief, keeping in mind potential for gas-bloating and dysphagia in over half […]
Predicting Recurrence in Lymph Node-Negative Pancreatic Tumors
A new risk score for lymph node-negative pancreatic neuroendocrine tumors helps identify patients at risk for recurrence and guides postoperative surveillance. Recurrence rate for lymph node-negative patients was 10.6%, occurring at a median of 32.4 months post-surgery. Risk factors included male sex (2.2x), tumor size ≥3 cm (2.64x), grade 2 or higher (3.70x), and lymphovascular […]
Disparities Impact Pancreatic Cancer Outcomes
Multimodal treatment disparities in pancreatic cancer significantly affect patient survival and care. 8,466 patients analyzed; nonmetastatic cases had higher therapy rates than metastatic. Non-Hispanic black patients experienced longer delays to treatment compared to non-Hispanic whites. Uninsured and Medicaid patients showed the highest odds of not receiving therapy in metastatic cases. Primary resection strongly predicts improved […]
Predicting Pancreatic Fistula Risk with Elastography
Pre-operative shear wave elastography can effectively predict the risk of post-operative pancreatic fistula (POPF) after partial pancreatectomy, impacting surgical decision-making. In a study of 305 patients, lower elastography measurements correlated with a higher risk of POPF. An integrated prediction model using elastography, BMI, and pancreatic duct dilation accurately assessed POPF risk with AUC values over […]
Conversion Resection Improves Outcomes in Intermediate-Stage HCC
Preoperative conversion therapy significantly enhances surgical outcomes for intermediate-stage hepatocellular carcinoma. 23.2% of patients in the conversion resection group achieved a complete pathological response. Microvascular invasion rates were lower in the conversion group (17.9% vs. 58.6% in direct resection). Consider conversion therapy to improve pathology and survival before resection in select patients. 51.8% of the […]
Outcomes for Retroperitoneal Sarcoma Patients Improve Significantly
Recent management of primary retroperitoneal sarcomas shows improved survival rates over time. 5-year overall survival increased from 61.7% (2002-2011) to 78.8% (2012-2021). Distant metastases rates decreased in the recent cohort (HR 1.50). These findings influence patient selection and highlight the need to adopt newer treatment strategies to enhance outcomes. 30-month post-recurrence survival rose dramatically from […]